The Perimenopause Revolution: A Glimpse into America's Future of Medicine The recent surge in demand for hormone therapy is driven by a combination of factors, including the removal of "black box" warnings and the growth of telehealth startups.
This phenomenon represents more than just a response to a medical issue – it's a harbinger of a fundamental shift in how Americans approach healthcare.
For years, women like Lisa Schrenk were denied hormone therapy due to misplaced fears about cancer risks. The FDA's decision to remove these warnings was long overdue.